» Articles » PMID: 25847891

Smoking, Diabetes, Blood Hypertension: Possible Etiologic Role for Peyronie's Disease? Analysis in 279 Patients with a Control Group in Sicily

Overview
Publisher PagePress
Date 2015 Apr 8
PMID 25847891
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the proportion of patients with Peyronie's Disease (PD) and the possible association with its potential risk factors in the general population of the central and western Sicily in our weekly andrological outpatient clinic.

Materials And Methods: We recruited a sample of 279 consecutive patients consulting our andrological outpatient clinic. Two arms were created: the first one composed by PD patients (men with symptoms suggestive for PD), the second one composed by patients with other andrological diseases (control arm). For each patient we evaluated the age, cigarette smoking, diabetes, blood hypertension and erectile function. In the PD arm we administered validated questionnaires to determine the erectile function status by the International Index of Erectile Function 5 (IIEF-5) and the pain status during erection by the Visual Analogue Scale (VAS). A univariate analysis was conducted using R software.

Results: We enrolled 279 consecutive patients. The number of PD patients was 97 (34,7%). The univariate analysis showed a correlation between PD and cigarette smoking (p = 0.0242), blood hypertension (p < 0.001), erectile dysfunction (p < 0.001). No significant association was observed between diabetes and PD (p = 0.358). The median age of PD arm was 60 years and the median age of the control arm was 63,5 years; therefore the median age of PD arm resulted lower than the median age of the control arm (p = 0,031).

Conclusions: Peyronie's disease is more common than we might think; furthermore it can be diagnosed among young patients. According to our results, cigarette smoking and blood hypertension may be considered statically significant risk factors for developing PD. On the contrary diabetes seems not to be a risk factor for PD. According to our results PD should be sought also in young patients. Further studies are necessary to confirm that removing the indicated risk factors may reduce the incidence of PD.

Citing Articles

Effects of therapy in experimental models of Peyronie's disease: a scoping review.

Wiborg M, Kroijer R, Laursen B, Lund L Sex Med. 2025; 12(6):qfae088.

PMID: 39807474 PMC: 11726063. DOI: 10.1093/sexmed/qfae088.


Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?.

Crocetto F, Imbimbo C, Barone B, Turchino D, Bracale U, Peluso A Basic Clin Androl. 2023; 33(1):38.

PMID: 38110896 PMC: 10729439. DOI: 10.1186/s12610-023-00213-y.


The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review.

Yang C, Lin D, Lin Y, Hsu C, Tung M, Tan K Int J Mol Sci. 2023; 24(1).

PMID: 36614220 PMC: 9821411. DOI: 10.3390/ijms24010777.


Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system.

Nackeeran S, Zucker I, Efimenko I, Weber A, Brown S, Ramasamy R Int J Impot Res. 2022; 35(8):706-711.

PMID: 36151319 DOI: 10.1038/s41443-022-00615-y.


Significant familial clustering of Peyronie's disease in close and distant relatives.

Allen-Brady K, Christensen M, Sandberg A, Pastuszak A Andrology. 2022; 10(7):1361-1367.

PMID: 35770847 PMC: 9481671. DOI: 10.1111/andr.13223.